Categories  |  Inventors

Technology Overview

OHSU # 1038B — HPi2 monoclonal antibody supernatant from hybridoma HIC1-2B4 (endocrine cell marker)

Technology Overview

The monoclonal antibody HPi2 is derived from the hybridoma HIC1-2B4.  HPi2 selectively reacts with a cell surface module on human pancreatic endocrine cells. This antibody reacts with multiple endocrine cell types.
 
Antibody: HPi2 Supernatant
Hybridoma cell line: HIC1-2B4
Isotype: Mouse IgG1
Species reactivity: Human
Applications: Immunohistochemistry (acetone fixation recommended), Flow cytometry
Availability:  1mL supernatant aliquot.
 
 
 

Inventors:

Related Technologies

  • OHSU # 1038B-1 — Purified HPi2 antibody from hybridoma HIC1-2B4 (endocrine cell marker)
  • OHSU # 1038B-2 — APC conjugated HPi2 antibody from hybridoma HIC1-2B4 (endocrine cell marker)
  • OHSU # 1038A — HPi1 monoclonal antibody supernatant from hybridoma HIC0-4F9 (endocrine cell marker)
  • OHSU # 1038F — HPs1 monoclonal antibody supernatant from hybridoma HIC0-3C5 (islet cell subset marker)
  • OHSU # 1038G — HPa1 monoclonal antibody supernatant from hybridoma DHIC2-2C12 (alpha cell marker)
  • OHSU # 1038H — HPa2 Monoclonal Antibody Supernatant from Hybridoma DHIC2-2B4 (alpha cell marker)
  • OHSU # 1038I — HPx2 monoclonal antibody supernatant from hybridoma HIC1-1C10 (exocrine cell marker)
  • OHSU # 1038J — HPd1 monoclonal antibody supernatant from hybridoma DHIC2-4A10 (duct cell marker)
  • OHSU # 1038K — HPd2 monoclonal antibody supernatant from hybridoma DHIC3-5H10 (duct cell marker)

Categories: